Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trialSherene Loi, Christos Sotiriou, Stefan Michiels et al.|Annals of Oncology|2014Cited by 1.3k
The 2019 World Health Organization classification of tumours of the breastPuay Hoon Tan, Ian O. Ellis, Kimberly H. Allison et al.|Histopathology|2020Cited by 1.1k
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B. Johnson, Justin M. Balko, Allison R. Greenplate et al.|Nature Communications|2016Cited by 572
Principles Governing A-to-I RNA Editing in the Breast Cancer TranscriptomeDebora Fumagalli, Vincent Detours, David Gacquer et al.|Cell Reports|2015Cited by 249
Societal challenges of precision medicine: Bringing order to chaosRoberto Salgado, Nils Wilking, Helen M. Moore et al.|European Journal of Cancer|2017Cited by 29